Anti-Bad antibody
4
(1 Review)
|
(40 Publications)
Rabbit Polyclonal BAD antibody. Suitable for WB, IHC-P and reacts with Mouse samples. Cited in 40 publications.
View Alternative Names
Bbc6, Bad, Bcl2-associated agonist of cell death, BAD, Bcl-2-binding component 6, Bcl-xL/Bcl-2-associated death promoter, Bcl2 antagonist of cell death
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bad antibody (AB90435)
ab90435, at a 1/50 dilution, staining BAD in the neurons of paraffin embedded Alzheimer diseased brain tissue (right) by Immunohistochemistry. Control brain tissue (left).
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Its main role is to promote apoptosis by binding to anti-apoptotic proteins like Bcl-2 and Bcl-XL displacing pro-apoptotic Bax and Bak proteins to trigger cell death. Bad functions as part of the mitochondrial apoptosis pathway and is known to form complexes with phosphorylated proteins. Phosphorylation of Bad by kinases can lead to its sequestration to the cytoplasm reducing apoptosis.
Pathways
Its action is pivotal in the PI3K/Akt signaling pathway. This pathway involves growth factors and cell survival signals where phosphorylation of Bad inhibits its pro-apoptotic activity. Bad interacts with proteins like Akt and 14-3-3 to modulate cell survival. Disruption in its regulation through these pathways may lead to abnormal cell survival or death.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (40)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 26: PubMed39796130
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 24:261 PubMed35765271
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:3596-3607 PubMed35112987
2022
Applications
Unspecified application
Species
Unspecified reactive species
In vivo (Athens, Greece) 35:2599-2608 PubMed34410947
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:713715 PubMed34381366
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 12:707634 PubMed34305656
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:486 PubMed33790995
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 17:318 PubMed33100225
2020
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 15:e0235404 PubMed32785222
2020
Applications
Unspecified application
Species
Unspecified reactive species
Anticancer research 40:3819-3830 PubMed32620621
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com